Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Aaby

Showing results (391-400 of 445) with videos related to

Pageof 45
Sort By:
International Journal of Epidemiology|June 13, 2014
The non-specific effects of vaccines and other childhood interventions: the contribution of INDEPTH Health and Demographic Surveillance SystemsOsman Sankoh, Paul Welaga, Cornelius Debpuur, et al.
Frontiers in Public Health|October 24, 2022
One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19Angela Y Chang, Peter Aaby, Michael S Avidan, et al.
Journal of the Pediatric Infectious Diseases Society|February 5, 2019
Maternal Priming: Bacillus Calmette-Guérin (BCG) Vaccine Scarring in Mothers Enhances the Survival of Their Child With a BCG Vaccine ScarMike L T Berendsen, Christian Bjerregård Øland, Pauli Bles, et al.
Contemporary Clinical Trials|April 22, 2015
Bacillus Calmette-Guérin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trialLisbeth Marianne Thøstesen, Thomas Nørrelykke Nissen, Jesper Kjærgaard, et al.
Vaccine|April 10, 2016
Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trialThomas Nørrelykke Nissen, Nina Marie Birk, Jesper Kjærgaard, et al.
Clinical Immunology (Orlando, Fla.)|December 24, 2022
The impact of BCG dose and revaccination on trained immunityPriya A Debisarun, Gizem Kilic, L Charlotte J de Bree, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 14, 2011
Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countriesLasse Vinner, Birgitta Holmgren, Kristoffer J Jensen, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2017
Neonatal BCG vaccination has no effect on recurrent wheeze in the first year of life: A randomized clinical trialLisbeth Marianne Thøstesen, Lone Graff Stensballe, Gitte Thybo Pihl, et al.
Journal of Innate Immunity|November 7, 2013
Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunityJohanneke Kleinnijenhuis, Jessica Quintin, Frank Preijers, et al.
Journal of the Pediatric Infectious Diseases Society|April 11, 2018
BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter TrialLone Graff Stensballe, Henrik Ravn, Nina Marie Birk, et al.
Pageof 45

Showing results (391-400 of 445) with videos related to

Sort By:
Pageof 45
International Journal of Epidemiology|June 13, 2014
The non-specific effects of vaccines and other childhood interventions: the contribution of INDEPTH Health and Demographic Surveillance SystemsOsman Sankoh, Paul Welaga, Cornelius Debpuur, et al.
Frontiers in Public Health|October 24, 2022
One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19Angela Y Chang, Peter Aaby, Michael S Avidan, et al.
Journal of the Pediatric Infectious Diseases Society|February 5, 2019
Maternal Priming: Bacillus Calmette-Guérin (BCG) Vaccine Scarring in Mothers Enhances the Survival of Their Child With a BCG Vaccine ScarMike L T Berendsen, Christian Bjerregård Øland, Pauli Bles, et al.
Contemporary Clinical Trials|April 22, 2015
Bacillus Calmette-Guérin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trialLisbeth Marianne Thøstesen, Thomas Nørrelykke Nissen, Jesper Kjærgaard, et al.
Vaccine|April 10, 2016
Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trialThomas Nørrelykke Nissen, Nina Marie Birk, Jesper Kjærgaard, et al.
Clinical Immunology (Orlando, Fla.)|December 24, 2022
The impact of BCG dose and revaccination on trained immunityPriya A Debisarun, Gizem Kilic, L Charlotte J de Bree, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 14, 2011
Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countriesLasse Vinner, Birgitta Holmgren, Kristoffer J Jensen, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2017
Neonatal BCG vaccination has no effect on recurrent wheeze in the first year of life: A randomized clinical trialLisbeth Marianne Thøstesen, Lone Graff Stensballe, Gitte Thybo Pihl, et al.
Journal of Innate Immunity|November 7, 2013
Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunityJohanneke Kleinnijenhuis, Jessica Quintin, Frank Preijers, et al.
Journal of the Pediatric Infectious Diseases Society|April 11, 2018
BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter TrialLone Graff Stensballe, Henrik Ravn, Nina Marie Birk, et al.
Pageof 45